Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 15.72M P/E - EPS this Y 56.90% Ern Qtrly Grth -
Income -25.31M Forward P/E -0.67 EPS next Y -31.80% 50D Avg Chg -24.00%
Sales 613.42k PEG - EPS past 5Y - 200D Avg Chg -48.00%
Dividend N/A Price/Book 0.95 EPS next 5Y - 52W High Chg -87.00%
Recommedations 1.50 Quick Ratio 4.47 Shares Outstanding 60.26M 52W Low Chg 8.00%
Insider Own 3.19% ROA -133.75% Shares Float 58.45M Beta 0.18
Inst Own 6.64% ROE -364.04% Shares Shorted/Prior 2.44M/485.14K Price 0.26
Gross Margin - Profit Margin - Avg. Volume 7,365,236 Target Price 2.25
Oper. Margin -4,146.95% Earnings Date May 16 Volume 1,049,992 Change 1.61%

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.

SONN Chatroom

User Image Fistfullofdynomite Posted - 2 hours ago

$SONN Accumulating, easy money within the next 30 to 60 days.

User Image bamabud Posted - 7 hours ago

$SONN should I average down from my $5 average or is this completely dead? Good luck everyone

User Image ablairy86 Posted - 7 hours ago

$SONN ohhhh just gonna hold until they can sell their vehicle for cancer meds and vaccines. Easy. This thing gonna go when it does ans I’ll be ready.

User Image shortvolumes Posted - 1 day ago

Short sale volume (not short interest) for $SONN on 2022-05-13 is 54%. http://shortvolumes.com/?t=SONN via @shortvolumes

User Image LightTrader1 Posted - 1 day ago

$MULN $SONN Both Earnings Call

User Image LightTrader1 Posted - 1 day ago

$SONN let's go 2$

User Image tickeron Posted - 2 days ago

Is this good for your portfolio? $SONN enters a Downtrend because Momentum Indicator dropped below the 0 level on April 13, 2022. View odds for this and other indicators: https://srnk.us/go/3665819

User Image entitycs Posted - 4 days ago

$NDRA and $SONN are both laughable stocks. But also, I have them on my watch list, just in case...

User Image LightTrader1 Posted - 4 days ago

$SONN Major Pump coming ER Monday.. loading up is the way

User Image LightTrader1 Posted - 4 days ago

$SONN Earnings for Sonnet BioTherapeutics are expected to grow in the coming year, from ($0.39) to ($0.32) per share. Sonnet BioTherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 16th, 2022 based off prior year's report dates.

User Image Warlord2580 Posted - 4 days ago

$SONN Compliance for the $1.00 bid rule must be regained by 10/03/2022. This was extended on 04/06/2022. From the 14 A on 04/13/2022 A R/S vote with a ratio between 1:2 to 1:20 will take place on 06/02/2022.

User Image doverthinker Posted - 4 days ago

$SONN Are we going to see teens next week ?πŸ€” I’m ready to add another 10 shares πŸ˜‡

User Image Melo1997 Posted - 5 days ago

$SONN volume??😜

User Image MC428 Posted - 5 days ago

$SONN Damn .24s

User Image STCKPRO Posted - 5 days ago

$SONN NEW ARTICLE : Analysts Are Bullish on These Healthcare Stocks: Sonnet BioTherapeutics Holdings (SONN), Tarsus Pharmaceuticals (TARS) https://www.stck.pro/news/SONN/27610571

User Image trd_stocks Posted - 5 days ago

$SONN looks a risky trade, but why shouldn't sonn go up?

User Image SmokeyJ2000 Posted - 5 days ago

$SONN Mohan owns roughly 1,300,000 million shares. Valued at roughly $325,000. His salary $734,000. He doesn’t give a shit about the stock price nor do any of the other execs

User Image MoonBounceCapital Posted - 5 days ago

$SONN There's a lot of problems with SONN and they're pretty much all poor management related, but the biggest is horrible public relations. Instead of hiding what they have going on in SEC filings they should be putting out press releases so their reaches more eyes. Take the word to the masses, don't make them search and/or come to you. Simple update/reminder press releases put out on a regular basis (at least weekly), like other successful companies do would have this holding over 1.00 easily. They would be in a much better position to raise significant funds in the future. Recently they went nearly seven months without putting out one press release leaving the public in the dark. Yea, that's pure incompetence. I guess the brilliant management at SONN has another plan. I'll consider buying back in if/when it goes sub 0.15 and even then, like I said, I would just CONSIDER it. There's thousands of better opportunities in the market to make bigger and quicker money.

User Image Jopa1818 Posted - 5 days ago

$SONN The board for this company should be locked up. This stock has gone down steady heavy for YEARS. I remem not that long ago it was $5-$6 and way more.. a fucking quarter? Haha. What a joke and thievery of a horseshit camel company.

User Image MinimumSweat Posted - 5 days ago

$SONN Jumped on hoping for a pump. GLTA, for my sake....

User Image Umama Posted - 6 days ago

$SONN this company is in an extremely bad situation for stockholders. They’ll run out of cash in 3 months and it’s at .25 cents a share. What are they gonna do, offer at .10 cents? Sorry guys, but it’s going much lower

User Image Kovi11 Posted - 6 days ago

$SONN Hey Pankaj You no good Currie eating piece of shit, I truly hope you DIe !!

User Image Sergeant_VIP Posted - 6 days ago

$SONN they have warrants that would fund then $30M plus at .85 cents. By having this they saved the extra time, paperwork, set up and more secure funding compare to an standard offering. The 8/2021 offering they barely manage to get $35M and BTIG was their investment firm at the time. They will pump this at anytime and no S-3 filling is required ( since it’s not an offering) and the hedge fund will short it down once is pass .85 and then they will cover using the warrants, this is Wall Street 101 how to trap new retail traders. June to July max is when we will see this kind of action. Or maybe tomorrow, but it’s definitely happening and these SP levels are great, don’t let any bears and fake bulls tell you otherwise.

User Image moneychaser33 Posted - 6 days ago

$SONN In the 10-Q, they said they have enough cash to run thru August 2022. Don’t expect an offering anytime before July. In the mean time, the stock will keep dropping. I’ll buy in the teens

User Image cctranscripts Posted - 6 days ago

Securities to be offered to employees in employee benefit plans https://www.conferencecalltranscripts.com/summary/?id=10824430 $SONN

User Image Quantisnow Posted - 1 week ago

$SONN πŸ“œ SEC Form S-8 filed by Sonnet BioTherapeutics Holdings Inc. https://quantisnow.com/i/2862843?utm_source=stocktwits 45 seconds delayed.

User Image ThailandRTO Posted - 1 week ago

$KTRA $SONN $USHAF KTRA averaged down but have done this way to many times. I tell myself it's the last time I do this. I would rather be buying a cheap position in USHAF with free spinco shares in a nickel company and buying LAC and other lithium and base metal stocks.

User Image cclink Posted - 1 week ago

$SONN Hoping this holds up with the earnings release. Surprised it didn't crash more, but glad it didn't.

User Image InsiderForms Posted - 1 week ago

Campion Asset Management,has filed Form 13F for Q1 2022.Opened NEW positions in $SONN

User Image Jrock149 Posted - 1 week ago

$SONN I've been watching and I'm ready to get back in this baby!!! πŸ˜πŸ˜πŸ˜πŸ‘€πŸ‘€πŸ‘€πŸ‘€πŸ‘€πŸ‘€πŸ‘€πŸ‘€πŸ‘€

Analyst Ratings
BTIG Buy Feb 9, 22
Chardan Capital Buy Dec 20, 21
HC Wainwright & Co. Buy Dec 16, 21
BTIG Buy Sep 15, 21
Chardan Capital Buy Sep 4, 20